Enanta Pharmaceuticals to Participate in September Investor Conferences
Business Wire•01/09/2026•07:00 ET
0
Whiz Insights
Enanta Pharmaceuticals to Participate in September Investor Conferences
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in two investor conferences in September:
Get started
Create a free account to read the full story.